AI-generated analysis. Always verify with the original filing.
On February 18, 2026, Outlook Therapeutics, Inc. filed an 8-K providing notice of delisting or failure to satisfy a continued listing rule or standard, with transfer of listing. Specific details of the delisting event were not disclosed in the provided document content.